Salvage reirradiation for recurrent glioblastoma with radiosurgery: Radiographic response and improved survival

Journal of Neuro-Oncology

Volumn 92, Issue 2, 2009, Pages 185-191

  Patel, Mehul ^a   Siddiqui, Farzan ^a   Jin, Jian Yue ^a   Mikkelsen, Tom ^a   Rosenblum, Mark ^a   Movsas, Benjamin ^a   Ryu, Samuel ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Glioblastoma; Radiosurgery; Radiotherapy; Recurrence; Reirradiation

Indexed keywords

BEVACIZUMAB; CARMUSTINE; ERLOTINIB; IRINOTECAN; LOMUSTINE; OXALIPLATIN; PROCARBAZINE; TEMOZOLOMIDE; VINCRISTINE;

ADULT; AGED; ARTICLE; ASTROCYTOMA; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLIOBLASTOMA; GLIOMA; HUMAN; MALE; MALIGNANT TRANSFORMATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; RADIATION DOSE; RECURRENT CANCER; SALVAGE THERAPY; STEREOTACTIC RADIOSURGERY;

ADULT; AGED; BRAIN NEOPLASMS; FEMALE; GLIOBLASTOMA; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOSURGERY; RETROSPECTIVE STUDIES; SALVAGE THERAPY;

EID: 61349125493     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-008-9752-9     Document Type: Article

References (27)

1. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996. doi: 10.1056/ NEJMoa043330
2. Bashir R, Hochberg F, Oot R (1988) Regrowth patterns of glioblastoma multiforme related to planning of interstitial brachytherapy radiation fields. Neurosurgery 23:27-30. doi: 10.1097/00006123-198807000-00006
3. Jansen EP, Dewit LG, van Herk M, Bartelink H (2000) Target volumes in radiotherapy for high-grade malignant glioma of the brain. Radiother Oncol 56:151-156. doi: 10.1016/S0167-8140(00)00216-4
4. Wallner KE, Galicich JH, Krol G, Arbit E, Malkin MG (1989) Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 16:1405-1409
5. Dirks P, Bernstein M, Muller PJ, Tucker WS (1993) The value of reoperation for recurrent glioblastoma. Can J Surg 36:271-275
6. Norden AD, Young GS, Setayesh K, Muzikansky A, Klufas R, Ross GL, Ciampa AS, Ebbeling LG, Levy B, Drappatz J, Kesari S, Wen PY (2008) Bevacizumab for recurrent malignant gliomas: Efficacy, toxicity, and patterns of recurrence. Neurology 70:779-787. doi: 10.1212/01.wnl.0000304121.57857.38
7. Vredenburgh JJ, Desjardins A, Herndon JE 2nd, Marcello J, Reardon DA, Quinn JA, Rich JN, Sathornsumetee S, Gururangan S, Sampson J, Wagner M, Bailey L, Bigner DD, Friedman AH, Friedman HS (2007) Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J Clin Oncol 25:4722-4729. doi: 10.1200/JCO.2007.12.2440
8. Hudes RS, Corn BW, Werner-Wasik M, Andrews D, Rosenstock J, Thoron L, Downes B, Curran WJ Jr (1999) A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma. Int J Radiat Oncol Biol Phys 43:293-298. doi: 10.1016/S0360-3016(98)00416-7
9. Mayer R, Sminia P (2008) Reirradiation tolerance of the human brain. Int J Radiat Oncol Biol Phys 70:1350-1360. doi: 10.1016/j.ijrobp.2007.08.015
10. Grossman SA, Fisher JD, Piantadosi S, Brem H (1998) The new approaches to brain tumor therapy (NABTT) CNS consortium: Organization, objectives, and activities. Cancer Control 5:107-114
11. Jin JY, Yin FF, Ryu S, Ajlouni M, Kim JH (2005) Dosimetric study using different leaf-width MLCs for treatment planning of dynamic conformal arcs and intensity-modulated radiosurgery. Med Phys 32:405-411. doi: 10.1118/1.1842911
12. Jin JY, Ryu S, Faber K, Mikkelsen T, Chen Q, Li S, Movsas B (2006) 2D/3D image fusion for accurate target localization and evaluation of a mask based stereotactic system in fractionated stereotactic radiotherapy of cranial lesions. Med Phys 33:4557-4566. doi: 10.1118/1.2392605
13. Lustig RA, Seiferheld W, Berkey B, Yung AW, Scarantino C, Movsas B, Jones CU, Simpson JR, Fishbach J, Curran WJ Jr (2007) Imaging response in malignant glioma, RTOG 90-06. Am J Clin Oncol 30:32-37. doi: 10.1097/ 01.coc.0000236214.13206.38
14. Norman D, Enzmann DR, Levin VA, Wilson CB, Newton TH (1976) Computed tomography in the evaluation of malignant glioma before and after therapy. Radiology 121:85-88
15. Brandsma D, Stalpers L, Taal W, Sminia P, van den Bent MJ (2008) Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol 9:453-461. doi: 10.1016/ S1470-2045(08)70125-6
16. Wong CS, Van der Kogel AJ (2004) Mechanisms of radiation injury to the central nervous system: Implications for neuroprotection. Mol Interv 4:273-284. doi: 10.1124/mi.4.5.7
17. Covarrubias DJ, Rosen BR, Lev MH (2004) Dynamic magnetic resonance perfusion imaging of brain tumors. Oncologist 9:528-537. doi: 10.1634/ theoncologist.9-5-528
18. Jain R, Scarpace L, Ellika S, Schultz LR, Rock JP, Rosenblum ML, Patel SC, Lee TY, Mikkelsen T (2007) First-pass perfusion computed tomography: initial experience in differentiating recurrent brain tumors from radiation effects and radiation necrosis. Neurosurgery 61:778-786 (discussion 786-777)
19. Nwokedi EC, DiBiase SJ, Jabbour S, Herman J, Amin P, Chin LS (2002) Gamma knife stereotactic radiosurgery for patients with glioblastoma multiforme. Neurosurgery 50:41-46 (discussion 46-47)
20. Buatti JM, Friedman WA, Bova FJ, Mendenhall WM (1995) Linac radiosurgery for high-grade gliomas: The University of Florida experience. Int J Radiat Oncol Biol Phys 32:205-210. doi: 10.1016/0360-3016(94)00498-A
21. Souhami L, Seiferheld W, Brachman D, Podgorsak EB, Werner-Wasik M, Lustig R, Schultz CJ, Sause W, Okunieff P, Buckner J, Zamorano L, Mehta MP, Curran WJ Jr (2004) Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: Report of Radiation Therapy Oncology Group 93-05 protocol. Int J Radiat Oncol Biol Phys 60:853-860. doi: 10.1016/ j.ijrobp.2004.04.011
22. Kondziolka D, Flickinger JC, Bissonette DJ, Bozik M, Lunsford LD (1997) Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms. Neurosurgery 41:776-783 (discussion 783-775)
23. Shepherd SF, Laing RW, Cosgrove VP, Warrington AP, Hines F, Ashley SE, Brada M (1997) Hypofractionated stereotactic radiotherapy in the management of recurrent glioma. Int J Radiat Oncol Biol Phys 37:393-398. doi: 10.1016/S0360-3016(96)00455-5
24. Vordermark D, Kolbl O, Ruprecht K, Vince GH, Bratengeier K, Flentje M (2005) Hypofractionated stereotactic reirradiation: Treatment option in recurrent malignant glioma. BMC Cancer 5:55. doi: 10.1186/1471-2407-5-55
25. Mandl ES, Dirven CM, Buis DR, Postma TJ, Vandertop WP (2008) Repeated surgery for glioblastoma multiforme: Only in combination with other salvage therapy. Surg Neurol 69:506-509 (discussion 509)
26. Lederman G, Wronski M, Arbit E, Odaimi M, Wertheim S, Lombardi E, Wrzolek M (2000) Treatment of recurrent glioblastoma multiforme using fractionated stereotactic radiosurgery and concurrent paclitaxel. Am J Clin Oncol 23:155-159. doi: 10.1097/00000421-200004000-00010
27. Schwer AL, Damek DM, Kavanagh BD, Gaspar LE, Lillehei K, Stuhr K, Chen C (2008) A phase I dose-escalation study of fractionated stereotactic radiosurgery in combination with gefitinib in patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 70(4):993-1001